Potential threat of therapeutic monoclonal antibodies against snake venom
Content Editor: Dr. Tanya Tanu
January 30, 2024 at 12:30:00 PM
Snake Bites, Antibody-dependent enhancement of toxicity, Monoclonal Antibody

Snake envenoming is among the Neglected Tropical Diseases, leading to significant mortality and disability in certain communities.
A recent study by Sorenson et al. published in Nature Communications suggests the causation of antibody-dependent enhancement of toxicity (ADET) by a potential therapeutic human monoclonal antibody.
This antibody was used to neutralize myotoxin-II from the pit viper Bothrops asper in representative mouse models, thereby increasing the toxin’s toxicity.
This report ADET of a toxin in animal studies highlights the necessity of assessing even well-known antibody formats in preclinical models to avoid potential deleterious effects as exemplified in the present study.
Click here to read more.
.png)